Clinical Trial Update: Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update comparing pharmacokinetics and safety of CKD-380 10 mg versus D308 10 mg in type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-380 (CKD-380)
• D308 (D308)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Type II Diabetes Mellitus | Phase 1 | Status: UNKNOWN